These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12650430)

  • 21. Determinants of drug response in camptothecin-11-resistant glioma cell lines.
    Matsumoto Y; Fujiwara T; Nagao S
    J Neurooncol; 1995; 23(1):1-8. PubMed ID: 7623066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
    Householder KT; DiPerna DM; Chung EP; Wohlleb GM; Dhruv HD; Berens ME; Sirianni RW
    Int J Pharm; 2015 Feb; 479(2):374-80. PubMed ID: 25562639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review on Camptothecin Analogs with Promising Cytotoxic Profile.
    Amin SA; Adhikari N; Jha T; Gayen S
    Anticancer Agents Med Chem; 2018; 18(13):1796-1814. PubMed ID: 29589546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationship of alkyl camptothecin esters.
    Cao Z; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Vardeman D; Liehr J; Stehlin JS; Giovanella B
    Ann N Y Acad Sci; 2000; 922():122-35. PubMed ID: 11193888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.
    Kuroda J; Kuratsu J; Yasunaga M; Koga Y; Saito Y; Matsumura Y
    Int J Cancer; 2009 Jun; 124(11):2505-11. PubMed ID: 19189401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
    Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
    Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.
    Kim TE; Park SY; Hsu CH; Dutschman GE; Cheng YC
    Mol Pharmacol; 2004 Aug; 66(2):285-92. PubMed ID: 15266019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin.
    Ng CE; Cybulski SE; Bussey AM; Aubin RA; Raaphorst GP
    Anticancer Res; 1998; 18(4C):3119-26. PubMed ID: 9713520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topoisomerase I-DNA complex stability induced by camptothecins and its role in drug activity.
    Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
    Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):327-34. PubMed ID: 15281905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents.
    Vladu B; Woynarowski JM; Manikumar G; Wani MC; Wall ME; Von Hoff DD; Wadkins RM
    Mol Pharmacol; 2000 Feb; 57(2):243-51. PubMed ID: 10648633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
    Zhao R; al-Said NH; Sternbach DL; Lown JW
    J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell lines.
    Borovitskaya AE; D'Arpa P
    Oncol Res; 1998; 10(5):271-6. PubMed ID: 9802062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
    Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
    Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C; Naumann U; Weller M
    Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.